Long-term lymphocytic leukemia (CLL) can be a lymphoid malignancy characterized by the proliferation and accumulation of experienced CD5+ B cells from the blood, bone marrow and lymphoid tissues. The prognosis of CLL calls for the existence of ≥five x109/L mono - clonal B cells of regular phenotype in the blood.Important differences in simultaneo